ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 114 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $386,081 | +55.6% | 121,792 | +143.9% | 0.00% | 0.0% |
| Q2 2023 | $248,187 | -11.5% | 49,937 | -12.0% | 0.00% | 0.0% |
| Q1 2023 | $280,469 | -77.7% | 56,775 | -71.7% | 0.00% | -80.0% |
| Q4 2022 | $1,260,290 | -52.6% | 200,364 | -18.7% | 0.01% | -61.5% |
| Q3 2022 | $2,660,000 | +8.4% | 246,322 | -8.5% | 0.01% | +30.0% |
| Q1 2022 | $2,454,000 | +515.0% | 269,320 | +1605.4% | 0.01% | +233.3% |
| Q4 2020 | $399,000 | +79.7% | 15,792 | +167.7% | 0.00% | 0.0% |
| Q3 2020 | $222,000 | -84.3% | 5,900 | -89.2% | 0.00% | -62.5% |
| Q4 2019 | $1,418,000 | +508.6% | 54,596 | +538.8% | 0.01% | +300.0% |
| Q3 2019 | $233,000 | -16.5% | 8,547 | -17.8% | 0.00% | -33.3% |
| Q2 2019 | $279,000 | -25.8% | 10,401 | -20.0% | 0.00% | -25.0% |
| Q1 2019 | $376,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |